All stocks · Healthcare · Health Care Equipment

Intuitive Surgical Inc ISRG

Intuitive Surgical Inc scores excellent on business quality (8.8 of 10). Here is why, in plain words, and what our sealed record shows.

Last price$423.96Oct 9, 2026
Business qualityExcellent
Next earningsOct 20, 2026, after the close
Insiders, 90 daysQuiet

Why it matters

  1. What Intuitive Surgical Inc does

    Intuitive Surgical makes money by selling advanced robotic surgical systems, instruments, and accessories to hospitals and healthcare providers. Revenue is driven by high-margin recurring tool sales and procedure volumes.

  2. What it does best

    Intuitive dominates robotic surgery through its massive installed base of systems and unmatched surgeon familiarity. With a gross margin of 66.7%, it easily outperforms peers like ABT at 56.8%, protected by immense switching costs in hospital operating rooms.

  3. The main risk

    The primary threat is extreme valuation pressure. Trading well above intrinsic value at a price of 391.95 against an intrinsic value of 333.90, any minor slowdown in procedure growth risks triggering a sharp multiple contraction.

Quality, check by check

Scored against its own industry, from company filings.

ProfitabilityStrong

Operating margins sit at a stellar 31.3% with an FCF margin in the top quartile of its sector at the 88th percentile. This business scales efficiently, turning revenue growth directly into cash.

MoatStrong

High switching costs lock in hospitals and surgeons who train exclusively on its platform. It sits in the top decile of its sector for revenue growth at the 90th percentile, making new market entrants exceedingly rare.

GrowthFast

Revenue is growing at 20.5% annually, accelerating rapidly from past historical periods. Procedure adoption across international markets powers this robust expansion.

Financial healthStrong

Zero total debt and $6.0B in cash create an unassailable fortress balance sheet. Free cash flow surged to $3.2B, getting noticeably stronger year over year.

Insiders

Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.

No open market buys or unplanned sales by executives or directors.

Our sealed record on ISRG

Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.

The first sealed verdicts appear here on Oct 11, 2026.

Questions

Is ISRG a good business?

Intuitive Surgical Inc scores excellent on the Cluenex quality check (8.8 of 10), measured against its own industry. Profitability is strong, moat strong, growth fast and financial health strong.

Are insiders buying ISRG?

In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.

When does ISRG report earnings?

Oct 20, 2026, after the close.

For members

See ISRG today

  • Today's verdict on ISRG, and why
  • Fair value with cautious, base and optimistic cases
  • The exact price that would change the verdict
  • Which stocks each signal names, the night it fires
Open in Cluenex Free to start. First month of Core free.

Cite this page: Cluenex, “Intuitive Surgical Inc (ISRG)”, https://cluenex.com/stocks/isrg/, data as of Oct 10, 2026.